BioMarin to Participate in Three Upcoming Investor Conferences

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in three major investor conferences in November and December 2024.

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in three major investor conferences in November and December 2024. The company will present at the UBS Global Healthcare Conference on November 12 at 11:00 am PST, the Jefferies London Healthcare Conference on November 19 at 9:00 am GMT, and the 7th Annual Evercore ISI HealthCONx Conference on December 4 at 7:00 am PST.

Live audio webcasts of the presentations will be accessible through BioMarin's investor website, with archived versions available for -time replay.

Argus Session date unavailable

+0.17% session move Open Argus

Details

News Market Reaction – BMRN

The recorded move for BMRN in the trading session of this news was +0.17%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• UBS Global Healthcare Conference on November 12 at 11:00 am PST
• Jefferies London Healthcare Conference on November 19 at 9:00 am GMT
• 7th Annual Evercore ISI HealthCONx Conference on December 4 at 7:00 am PST

SAN RAFAEL, Calif., Nov. 6, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at three upcoming investor conferences.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult to treat genetic conditions. To learn more, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-investor-conferences-302296955.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What investor conferences will BioMarin (BMRN) attend in November-December 2024?

BioMarin will attend three conferences: UBS Global Healthcare Conference (Nov 12), Jefferies London Healthcare Conference (Nov 19), and Evercore ISI HealthCONx Conference (Dec 4).

How can investors access BioMarin's (BMRN) conference presentations in November 2024?

Investors can access live audio webcasts of the presentations through BioMarin's investor website at https://investors.biomarin.com/.

What time is BioMarin's (BMRN) presentation at the UBS Global Healthcare Conference in November 2024?

BioMarin will present at the UBS Global Healthcare Conference on November 12 at 11:00 am PST.

Will BioMarin's (BMRN) investor conference presentations be available for replay?

Yes, archived versions of the presentations will be available through BioMarin's website for a time following each conference.